CN100400050C - 用于治疗胃肠疾病的稳定药物组合物 - Google Patents
用于治疗胃肠疾病的稳定药物组合物 Download PDFInfo
- Publication number
- CN100400050C CN100400050C CNB038032406A CN03803240A CN100400050C CN 100400050 C CN100400050 C CN 100400050C CN B038032406 A CNB038032406 A CN B038032406A CN 03803240 A CN03803240 A CN 03803240A CN 100400050 C CN100400050 C CN 100400050C
- Authority
- CN
- China
- Prior art keywords
- suspension
- pharmaceutically acceptable
- bismuth
- clay
- suspending agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
悬浮液 | 初始pH值 | 1个月的pH值 | 4个月的pH值 | 9个月的pH值 | 20个月的pH值 |
SS1 | 3.52 | 3.70 | 3.88 | 3.93 | 3.99 |
SS2 | 4.27 | 5.68 | 5.86 | 6.24 | 6.52 |
组分 | S1 | S2 | S3 | S4 | S5 |
碱式水杨酸铋USP | 1.746 | 1.746 | 1.746 | 1.746 | 1.746 |
水杨酸USP | 0.122 | 0.122 | 0.122 | 0.122 | 0.122 |
苯甲酸钠NF | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
山梨酸NF | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
蔗糖NF | 12.0 | 12.0 | 12.0 | 12.0 | 12.0 |
调味剂 | 0.15 | -- | 0.05 | 0.05 | 0.05 |
焦糖NF | 0.10 | 0.2 | 0.2 | 0.2 | 0.2 |
水杨酸钠USP | 0.40 | 0.4 | 0.4 | 0.4 | 0.4 |
黄原胶NF | 0.50 | 0.5 | 0.5 | 0.5 | 0.1 |
硅酸铝镁NF型IIA | 2.0 | -- | -- | -- | -- |
羧甲基纤维素钠USP | -- | -- | 2.0 | 0.5 | -- |
微晶纤维素NF | -- | -- | -- | -- | -- |
Avicel RC-591 | -- | 2.0 | -- | -- | -- |
水USP | 加至100 | 加至100 | 加至100 | 加至100 | 加至100 |
组分 | S6 | S7 | S8 | S9 |
碱式水杨酸铋USP | 1.746 | 1.746 | 1.746 | 1.746 |
水杨酸USP | 0.122 | 0.122 | 0.122 | 0.122 |
苯甲酸钠NF | 0.10 | 0.10 | 0.10 | 0.10 |
山梨酸NF | 0.10 | 0.10 | 0.10 | 0.10 |
蔗糖NF | 12.0 | 12.0 | 12.0 | 12.0 |
调味剂 | 0.15 | 0.15 | 0.15 | 0.15 |
焦糖NF | 0.05 | 0.05 | 0.05 | 0.01 |
水杨酸钠USP | 0.40 | 0.40 | 0.40 | 0.40 |
黄原胶NF | 0.6 | 0.75 | 0.5 | 0.5 |
硅酸铝镁NF型IIA | -- | -- | -- | -- |
羧甲基纤维素钠USP | -- | -- | -- | -- |
微晶纤维素NF | -- | -- | 2.0 | 3.0 |
Avicel RC-591 | -- | -- | -- | -- |
水USP | 加至100 | 加至100 | 加至100 | 加至100 |
悬浮液 | 初始pH值 | 最终pH值 | 贮存的月数 | 总的pH值增加 | 每个月平均pH值增加 |
S1 | 4.26 | 4.91 | 10 | 0.65 | 0.065 |
S2 | 4.02 | 4.02 | 12 | 0.0 | 0.0 |
S3 | 4.70 | 4.63 | 12 | (0.07) | (0.0058) |
S4 | 4.25 | 4.18 | 11 | (0.07) | (0.0064) |
S5 | 3.80 | 3.82 | 12 | 0.02 | 0.0016 |
S6 | 3.79 | 3.82 | 12 | 0.03 | 0.0025 |
S7 | 3.82 | 3.82 | 12 | 0.0 | 0.0 |
S8 | 3.82 | 3.85 | 11 | 0.03 | 0.0027 |
S9 | 3.85 | 3.87 | 11 | 0.02 | 0.0018 |
组成 | S10 |
碱式水杨酸铋USP | 3.5 |
水杨酸USP | 0.122 |
苯甲酸钠NF | 0.10 |
山梨酸NF | 0.10 |
蔗糖NF | 12.0 |
调味剂 | 0.15 |
焦糖NF | 0.05 |
水杨酸钠USP | 0.40 |
黄原胶NF | 0.5 |
Avicel RC-591 | 2.0 |
水USP | 加至100 |
组分 | S11 | S12 |
碱式水杨酸铋 | 1.746 | 1.746 |
山梨酸 | 0.2 | 0.2 |
水杨酸USP | 0.122 | 0.122 |
蔗糖 | 12 | 12 |
二氧化钛 | 0.4 | 0.4 |
Avicel RC-591 | 2 | 2 |
黄原胶 | 0.5 | 0.5 |
薄荷调味剂 | 0.1 | 0.1 |
FD&C 红#40 | 0.01 | 0.01 |
焦糖 | 0.1 | 0.1 |
水杨酸钠 | 0.4 | 0.4 |
FG-10消泡剂(Dow) | 0.01 | -- |
二甲基硅油 | -- | 0.8 |
水 | 加至100 | 加至100 |
Claims (26)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35422402P | 2002-02-04 | 2002-02-04 | |
US60/354,224 | 2002-02-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1627950A CN1627950A (zh) | 2005-06-15 |
CN100400050C true CN100400050C (zh) | 2008-07-09 |
Family
ID=27734335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB038032406A Expired - Fee Related CN100400050C (zh) | 2002-02-04 | 2003-02-03 | 用于治疗胃肠疾病的稳定药物组合物 |
Country Status (6)
Country | Link |
---|---|
US (2) | US7135197B2 (zh) |
CN (1) | CN100400050C (zh) |
AU (1) | AU2003210812A1 (zh) |
CA (1) | CA2474634C (zh) |
HK (1) | HK1074168A1 (zh) |
WO (1) | WO2003066022A2 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004077434A1 (en) * | 2003-02-25 | 2004-09-10 | Lg Electronics Inc. | Method of reproducing content information for an interactive optical disc apparatus |
US20050031706A1 (en) * | 2003-08-06 | 2005-02-10 | Pena Lorraine E. | Viscosity-stable compositions useful for treating gastrointestinal disorders |
US7473684B2 (en) * | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
US20070248564A1 (en) * | 2006-04-25 | 2007-10-25 | Roxane Laboratories, Inc. | Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia |
CN101652150B (zh) * | 2006-12-01 | 2013-12-11 | 韦克福里斯特大学健康科学院 | 结合胶原抑制剂的医疗装置 |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
WO2012162466A1 (en) * | 2011-05-25 | 2012-11-29 | Siemens Healthcare Diagnostics Inc. | Microbicidal compositions and methods of production use thereof |
AU2015253187B2 (en) | 2014-04-29 | 2017-10-05 | The Procter & Gamble Company | Method for making bismuth-containing liquid pharmaceutical suspensions |
US9486460B2 (en) | 2014-04-29 | 2016-11-08 | The Procter & Gamble Company | Bismuth containing liquid pharmaceutical suspensions |
CN108721325B (zh) * | 2017-04-13 | 2020-03-06 | 辽宁大熊制药有限公司 | 蒙脱石混悬液及其制备方法 |
WO2019040878A1 (en) * | 2017-08-25 | 2019-02-28 | L. Perrigo Company | PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2073254A2 (en) * | 1969-12-04 | 1971-10-01 | Dausse Laboratoire | Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders |
GB2073254A (en) * | 1980-04-09 | 1981-10-14 | Atomic Energy Authority Uk | Ion implanting metal coated ferrous surfaces |
US4801454A (en) * | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
US5013560A (en) * | 1989-03-17 | 1991-05-07 | The Procter & Gamble Company | Microbially-stable bismuth-containing liquid pharmaceutical suspensions |
FR2703250A1 (fr) * | 1993-03-30 | 1994-10-07 | Chicouri Marcel | Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6197M (zh) * | 1967-04-12 | 1968-07-22 | ||
IL32020A (en) | 1968-04-18 | 1972-11-28 | Brown G | Antacid compositions |
US4514510A (en) * | 1983-09-08 | 1985-04-30 | American Colloid Company | Hydrogen enriched water swellable clay having reduced acid demand and stable at low pH |
EP0217440A1 (en) | 1985-09-27 | 1987-04-08 | The Procter & Gamble Company | Stable aqueous pharmaceutical suspensions |
US4940695A (en) * | 1987-12-10 | 1990-07-10 | The Procter & Gamble Company | Bismuth-containing pharmaceutical compositions |
US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
-
2003
- 2003-02-03 WO PCT/US2003/003150 patent/WO2003066022A2/en not_active Application Discontinuation
- 2003-02-03 CN CNB038032406A patent/CN100400050C/zh not_active Expired - Fee Related
- 2003-02-03 AU AU2003210812A patent/AU2003210812A1/en not_active Abandoned
- 2003-02-03 CA CA2474634A patent/CA2474634C/en not_active Expired - Fee Related
- 2003-02-03 US US10/356,915 patent/US7135197B2/en active Active
-
2005
- 2005-08-02 HK HK05106597A patent/HK1074168A1/xx not_active IP Right Cessation
- 2005-11-01 US US11/263,700 patent/US20060057225A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2073254A2 (en) * | 1969-12-04 | 1971-10-01 | Dausse Laboratoire | Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders |
GB2073254A (en) * | 1980-04-09 | 1981-10-14 | Atomic Energy Authority Uk | Ion implanting metal coated ferrous surfaces |
US4801454A (en) * | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
US5013560A (en) * | 1989-03-17 | 1991-05-07 | The Procter & Gamble Company | Microbially-stable bismuth-containing liquid pharmaceutical suspensions |
FR2703250A1 (fr) * | 1993-03-30 | 1994-10-07 | Chicouri Marcel | Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation. |
Also Published As
Publication number | Publication date |
---|---|
WO2003066022A3 (en) | 2004-01-22 |
US20030215524A1 (en) | 2003-11-20 |
CA2474634C (en) | 2010-10-19 |
CN1627950A (zh) | 2005-06-15 |
CA2474634A1 (en) | 2003-08-14 |
US7135197B2 (en) | 2006-11-14 |
WO2003066022A2 (en) | 2003-08-14 |
HK1074168A1 (en) | 2005-11-04 |
AU2003210812A1 (en) | 2003-09-02 |
AU2003210812A8 (en) | 2003-09-02 |
US20060057225A1 (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060057225A1 (en) | Stable pharmaceutical composition useful for treating gastrointestinal disorders | |
US4713246A (en) | Etoposide oral dosage form | |
TW406023B (en) | Pharmaceutical formulations containing voriconazole | |
EP0349235A2 (en) | Niacin and guar-gum containing composition | |
ZA200307684B (en) | Antifungal composition with enhanced bioavailability | |
AU2002257104A1 (en) | Antifungal composition with enhanced bioavailability | |
CN104800167B (zh) | 一种氟苯尼考可溶性粉及其制备方法 | |
CN103228279A (zh) | 包含瑞伐拉赞或其盐的可注射液体组合物或可注射干粉 | |
CN110464846A (zh) | 一种美洛昔康组合物、制剂及其制备方法与应用 | |
CN1565430A (zh) | 大蒜素环糊精包合物、制剂及制备方法 | |
CN108261398A (zh) | 一种含有左西孟旦的供注射用药物制剂及其制备方法 | |
CN101544638B (zh) | 乳酸咯萘啶及其药物组合物 | |
CN101001621A (zh) | 包含加巴喷丁的药物组合物 | |
CN102688189B (zh) | 一种鲁拉西酮药物组合物和制法 | |
CN106265534A (zh) | 一种泊沙康唑冻干粉针剂的制备方法 | |
US2841526A (en) | Fatty acid-resin adsorption product | |
CA1238578A (en) | Etoposide oral dosage form | |
US4981852A (en) | Chemical compounds triamterene and hydrochlorothiazide | |
DE69819203T2 (de) | Trinkbares arzneimittel | |
US20030225032A1 (en) | Pharmaceutical composition | |
EP0384722B1 (en) | Chemical compositions | |
US20050031706A1 (en) | Viscosity-stable compositions useful for treating gastrointestinal disorders | |
WO2008098586A1 (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
CN107683145A (zh) | 具有高抗微生物能力的有机柑橘类提取物作为液体、乳液、悬浮液、霜膏和抗酸剂中的防腐剂体系的用途 | |
Bennion et al. | The use of single-agent antibacterial regimens in the treatment of advanced appendicitis with peritonitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1074168 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: MAXNELL-PPC CO., LTD. Free format text: FORMER OWNER: PHARMACIA CORPORATION Effective date: 20070720 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070720 Address after: new jersey Applicant after: Macneil, -PPC, Limited by Share Ltd Address before: American Missouri Applicant before: Pharmetrix Corporation |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1074168 Country of ref document: HK |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080709 Termination date: 20120203 |